| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense), net | 3,162 | -10,426 | 6,716 | 671 |
| Income (loss) before income taxes | 9,524 | -1,927 | 8,706 | -138,856 |
| Income tax expense | 4,092 | 2,920 | 3,894 | 4,610 |
| Net income (loss) | 5,432 | -4,847 | 4,812 | -143,466 |
| Basic (in shares) | 44,038,000 | 45,459,000 | 46,275,000 | 46,134,000 |
| Basic net income (loss) per common share (in dollars per share) | 0.12 | -0.11 | 0.1 | -3.11 |
| Diluted (in shares) | 44,459,000 | 45,459,000 | 46,526,000 | 46,134,000 |
| Diluted net income (loss) per common share (in dollars per share) | 0.12 | -0.11 | 0.1 | -3.11 |
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)